NGENLA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Mar 2025)
What this means for you
Registered since 05 Mar 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86730692
- Registration number
- 5692027
- Mark type
- Stylized text
- Filed
- 20 Aug 2015
- Published for opposition
- 08 Dec 2015
- Registered
- 05 Mar 2019
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 05 Mar 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 27 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 27 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 27 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 May 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 26 Mar 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED